Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes
Author:
Affiliation:
1. Department of Endocrinology, Huzhou Central Hospital
2. Department of Stomatology, Changhai Hospital, the Second Military Medical University
3. Department of Laboratory Diagnostic, Changhai Hospital, Second Military Medical University
Publisher
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine,Health(social science)
Reference18 articles.
1. 1. Van Cutsem E, Vervenne W L, Bennouna J, Humblet Y, Gill S, Van Laethem J L, Verslype C, Scheithauer W, Shang A, Cosaert J, Moore MJ. Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. J Clin Oncol. 2009; 27:2231-2237.
2. 2. Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: A potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 2009; 10:88-95.
3. 3. Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008; 134:981-987.
4. 4. Lai SW, Liao KF. New-onset diabetic patients need pancreatic cancer screening. J Clin Gastroenterol. 2013; 47:372.
5. 5. Mizuno S, Nakai Y, Isayama H, et al. Diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancer. Pancreatology. 2013; 13:285-289.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives;International Journal of Molecular Sciences;2024-08-24
2. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present;Biomolecules;2024-03-19
3. Glycemic Abnormalities in Pancreatic Cystic Lesions—A Single-Center Retrospective Analysis;Gastroenterology Insights;2023-05-04
4. The roles of osteoprotegerin in cancer, far beyond a bone player;Cell Death Discovery;2022-05-06
5. Prognostic Value of Serum Osteoprotegerin Level in Patients With Hepatocellular Carcinoma Following Surgical Resection;Frontiers in Oncology;2021-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3